- Home
- CTSO vs ONDS Comparison
CTSO vs ONDS Comparison
Compare CTSO & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- ONDS
- Stock Information
- Founded
- CTSO 1997
- ONDS N/A
- Country
- CTSO United States
- ONDS United States
- Employees
- CTSO N/A
- ONDS N/A
- Industry
- CTSO Medical/Dental Instruments
- ONDS Telecommunications Equipment
- Sector
- CTSO Health Care
- ONDS Telecommunications
- Exchange
- CTSO Nasdaq
- ONDS Nasdaq
- Market Cap
- CTSO 57.2M
- ONDS 62.6M
- IPO Year
- CTSO N/A
- ONDS N/A
- Fundamental
- Price
- CTSO $0.98
- ONDS $0.74
- Analyst Decision
- CTSO Strong Buy
- ONDS Strong Buy
- Analyst Count
- CTSO 3
- ONDS 2
- Target Price
- CTSO $4.67
- ONDS $2.50
- AVG Volume (30 Days)
- CTSO 147.2K
- ONDS 231.4K
- Earning Date
- CTSO 11-07-2024
- ONDS 11-12-2024
- Dividend Yield
- CTSO N/A
- ONDS N/A
- EPS Growth
- CTSO N/A
- ONDS N/A
- EPS
- CTSO N/A
- ONDS N/A
- Revenue
- CTSO $37,739,531.00
- ONDS $8,024,937.00
- Revenue This Year
- CTSO $13.09
- ONDS N/A
- Revenue Next Year
- CTSO $15.68
- ONDS $217.16
- P/E Ratio
- CTSO N/A
- ONDS N/A
- Revenue Growth
- CTSO 1.80
- ONDS N/A
- 52 Week Low
- CTSO $0.70
- ONDS $0.54
- 52 Week High
- CTSO $2.15
- ONDS $1.99
- Technical
- Relative Strength Index (RSI)
- CTSO 44.01
- ONDS 49.25
- Support Level
- CTSO $0.71
- ONDS $0.72
- Resistance Level
- CTSO $0.99
- ONDS $0.86
- Average True Range (ATR)
- CTSO 0.09
- ONDS 0.07
- MACD
- CTSO 0.00
- ONDS -0.00
- Stochastic Oscillator
- CTSO 59.97
- ONDS 40.98
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.